GSE183516
RNA-Seq of KRAS-regulated genes in human cell lines
Human cell lines were treated with a KRASG12C inhibitor or tamoxifen to activate KRAS for different time points. Then RNA was extracted for gene expression analysis to assess the role of KRAS signalling on immune-related genes. Overall design: RNA-Seq of two KRASG12C-mutant lung cancer cell lines and one normal lung cell line